Skip to content

Hypnion, founded in 2007, was a privately-held neuroscience drug discovery company focused on sleep disorder research. Hypnion’s proprietary sleep-wake drug discovery system, SCORE-2004™, was designed to be predictive of human response and to allow high-throughput pre-clinical testing of non-addictive sleep disorder drug candidates. The company was acquired by Eli Lilly in 2007.

Latest News from Hypnion